RxDoctor Payments Data

John Puccini, PA

Medical · Walnut Creek, CANPI 1528351814

Payments from drug & device makers

$1,734in general payments, 2019–2025

Across 41 payments — averaging $42.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$461
  • Boston Scientific$287
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$176
  • Lantheus Medical Imaging, Inc.$164
  • Boehringer Ingelheim$151
  • Inari Medical, Inc.$151
  • plus $344 from 4 others

What the payments were for

  • Food & beverage$1,734100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,734 in reported general payments places this provider in the 70th percentile of 2,087 medical providers in California.

See all medical providers in California

Medicare billing

Part B allowed, 2024
$3,345
Medicare patients
27
Services billed
32

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban62$91,309
EliquisApixaban51$77,161
EntrestoSacubitril/Valsartan44$61,989
JardianceEmpagliflozin30$45,991
FarxigaDapagliflozin Propanediol15$19,725
Ranolazine ErRanolazine27$4,127
Metoprolol Succinate239$3,141
Amiodarone Hcl43$1,561
Rosuvastatin Calcium39$1,426
Bumetanide24$1,235
Atorvastatin Calcium118$811
Carvedilol113$778
ClopidogrelClopidogrel Bisulfate38$537
Valsartan13$463
Lisinopril59$380

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
NovartisEntresto$93$61,98944 claims
Boehringer IngelheimJardiance$151$45,99130 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,087 medical providers in California.

Other medical in Walnut Creek

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →